Grace Therapeutics, Inc. (GRCE)

NCM – Real Time Price. Currency in USD

2.33

-0.02 (-0.85%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2024

2023

2022

2021

Total Revenue

Cost of goods sold

-7K

-11K

-124K

Gross Profit

-7K

-11K

-124K

Operating expenses (excl. COGS)

-17M

-11M

-18M

-16M

Operating Income

-17M

-11M

-18M

-16M

Non-operating income, total

-3M

-34M

Pretax income

-13M

-15M

-52M

-11M

Equity in earnings

Taxes

10M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-10M

-13M

-42M

-10M

Grace Therapeutics, Inc. (GRCE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Grace Therapeutics, Inc. (GRCE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Grace Therapeutics, Inc. (GRCE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Grace Therapeutics, Inc. (GRCE)

Income Statement (Annual)

Income Statement (Annual)